Risk factors of liver injury in patients with coronavirus disease 2019 in Jiangsu, China: A retrospective, multi‐center study
Jian Wang,Li Zhu,Leyang Xue,Longgen Liu,Xuebing Yan,Xiaomin Yan,Songping Huang,Biao Zhang,Tianmin Xu,Chunyang Li,Fang Ji,Fang Ming,Yun Zhao,Juan Cheng,Huaping Shao,Kang Chen,Xiang‐an Zhao,Dawen Sang,Haiyan Zhao,Xinying Guan,Xiaobing Chen,Yuxin Chen,Jiacheng Liu,Rui Huang,Chuanwu Zhu,Chao Wu
DOI: https://doi.org/10.1002/jmv.26663
IF: 20.693
2020-11-22
Journal of Medical Virology
Abstract:<p>We aimed to describe liver injury and identify the risk factors of liver injury in COVID‐19 patients without chronic liver diseases (CLD). The clinical data of 228 confirmed COVID‐19 patients without CLD were retrospectively collected from ten hospitals in Jiangsu, China. Sixty‐seven (29.4%) of 228 patients without CLD showed abnormal liver function on admission, including increased alanine aminotransferase (ALT, 25 [11.0%]) U/L, aspartate aminotransferase (AST, 30 [13.2%]) U/L, gamma‐glutamyl transferase (GGT, 28 [12.4%]) U/L, total bilirubin (Tbil, 16 [7.0%]) μmol/L, and alkaline phosphatase (ALP, 10 [4.5%]) U/L. During hospitalization, 129 (56.3%) of 228 patients showed abnormal liver function, including elevated ALT (84 [36.8%]), AST (58 [25.4%]), GGT (67 [29.5%]) and Tbil (59 [25.9%]). Age over 50 years (odds ratio [OR] 2.086, 95% confidence interval [CI] 1.030‐4.225, P=0.041), male sex (OR 2.737, 95%CI 1.418‐5.284, P=0.003), and lopinavir‐ritonavir (OR 2.504, 95%CI 1.187‐5.283, P=0.016) were associated with higher risk of liver function abnormality, while the atomized inhalation of interferon α‐2b (OR 0.256, 95%CI 0.126‐0.520, P<0.001) was associated with reduced risk of liver function abnormality during hospitalization. Mild to moderate liver injury was common in COVID‐19 patients in Jiangsu, China. Age over 50 years, male sex, and lopinavir‐ritonavir were the independent risk factors of liver impairment in COVID‐19 patients during hospitalization.</p><p>This article is protected by copyright. All rights reserved.</p>
virology